Theranos Inc. disclosed that it is under investigation by the U.S. Securities and Exchange Committee following scrutiny of its blood tests from federal and state health regulators. Bloomberg's Sheelah Kolhatkar explains how the investigation could impact the company's business on "Bloomberg Markets." (Source: Bloomberg)